Gallbladder carcinoma

Related records

Broader conditions (19)

• Cancer
• Cancer or benign tumor
• Carcinoma
• Digestive system cancer
• Digestive system carcinoma
• Digestive system disorder
• Digestive system neoplasm
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Epithelial neoplasm
• Gallbladder cancer
• Gallbladder disorder
• Gallbladder neoplasm
• Hepatobiliary disorder
• Hepatobiliary neoplasm
• Human disease
• Neoplasm
• Neoplastic disease or syndrome

Narrower conditions (10)

• Gall bladder carcinoma in situ
• Gallbladder adenocarcinoma
• Gallbladder adenosquamous carcinoma
• Gallbladder mucinous adenocarcinoma
• Gallbladder papillary neoplasm with an associated invasive carcinoma
• Gallbladder pleomorphic giant cell adenocarcinoma
• Gallbladder signet ring cell adenocarcinoma
• Gallbladder small cell neuroendocrine carcinoma
• Gallbladder squamous cell carcinoma
• Undifferentiated gallbladder carcinoma

Trials (53)

• A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP
• A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma Patients
• A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
• A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors
• A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors
• A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
• A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer
• A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer
• Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection
• Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
• Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma
• Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer
• Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer
• Comprehensive Genomic Profiling Combined With Real Life Data of "The German-Registry of Incidental Gallbladder Carcinoma"
• Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
• Cyclical Gemcitabine, Cisplatin, and Durvalumab Alternating With Pemigatinib for the Treatment of Unresectable, Locally Advanced or Metastatic Biliary Tract Cancers With FGFR2 Alterations
• Does Timing of Completion Radical Cholecystectomy Determine the Survival in Incidental Carcinoma Gallbladder
• Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer
• Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients
• Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

Drugs in development (16)

• Afatinib Phase 2
• Atezolizumab Phase 2
• Capecitabine Phase 3
• Carboplatin Phase 2
• Certepetide Phase 2
• Cisplatin Phase 3
• Cobimetinib Phase 2
• Durvalumab Phase 2
• Fluorouracil Phase 2
• Gemcitabine Phase 3
• Leucovorin calcium Phase 2
• Oxaliplatin Phase 3
• Rivoceranib Phase 2
• Selumetinib Phase 2
• Tegafur Phase 2
• Varlilumab Phase 2